Cannara Biotech Inc Capital Reinvestment Ratio
Cannara Biotech Inc capital reinvestment ratio. Cannara Biotech Inc (LOVE) has a Capital Reinvestment Ratio of 0.58x as of November 2025, meaning it reinvests 1% of its operating cash flow (CA$7.96 Million) in capital expenditures (CA$4.62 Million). See free cash flow generation of Cannara Biotech Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Cannara Biotech Inc (2023–2025)
Capital reinvestment ratio of Cannara Biotech Inc from 2023 to 2025. This chart tracks Cannara Biotech Inc's Capital Reinvestment Ratio across 3 annual periods. See LOVE free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cannara Biotech Inc Capital Reinvestment Ratio by Year (2023–2025)
Cannara Biotech Inc capital reinvestment ratio by year from 2023 to 2025. For the full cash flow conversion analysis, see Cannara Biotech Inc cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.32x | CA$20.01 Million | CA$6.36 Million | ▼ -54.6% |
| 2024 | 0.70x | CA$10.68 Million | CA$7.47 Million | ▼ -58.2% |
| 2023 | 1.67x | CA$5.91 Million | CA$9.88 Million | — |